MedWatch

Danish investors provoke life science industry's preference for Swedish stock market

Lacking interest from Danish investors is the reason why Danish life science companies deselect the domestic stock market. This is according to several companies that chose to go public in Sweden.

Foto: Nasdaq

Life science companies receive much more attention from investors in Sweden than in Denmark.

This is the consensus of several Danish companies in the biotech- medtech- or pharmaceutical industry that turned to the Swedish stock market to raise funds for the costly work of developing new products that will meet the healthcare sector's strict demands for documented effects.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier